Stocks rose on Wednesday by an impressive 2.5% following the Federal Reserve's final announcement on interest rates this year.

CEO, James Nathanielsz discusses the company’s groundbreaking therapy, PRP, and its potential to revolutionize cancer treatment.

Travere Therapeutics' completion of a successful pre-NDA meeting with the U.S. FDA for Filspari in IgA nephropathy has sent its stock skyrocketing by more than 30% in a single trading session.

Major automakers have been increasingly turning towards hybrid vehicles, reconsidering the viability of hybrid cars and trucks to deliver consumer demand and avoid costly penalties related to federal fuel economy and emissions standards.

Ispire Technology has been buzzing over social media after a solid result and a huge jump in its stock price.

In this article, we discuss the top ten small caps to have on your radar this December 2023.

As November closes out, the U.S. stock market is seeing a continued wave of optimism, marked by rallying Nasdaq and S&P futures on Wednesday morning.